SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·05/19/2025 17:05:59
Listen to the news
Gainers
- Protagenic Therapeutics (NASDAQ:PTIX) shares rose 286.8% to $11.72 during Monday's regular session. The company's market cap stands at $6.3 million. The company's, Q1 earnings came out 4 days ago.
- Healthcare Triangle (NASDAQ:HCTI) stock increased by 56.96% to $0.01.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 30.83% to $1.57. The market value of their outstanding shares is at $21.6 million.
- Abpro Hldgs (NASDAQ:ABP) shares rose 27.17% to $0.29. The market value of their outstanding shares is at $15.2 million.
- Tango Therapeutics (NASDAQ:TNGX) shares increased by 23.2% to $1.85. The company's market cap stands at $200.3 million.
- Novavax (NASDAQ:NVAX) stock moved upwards by 20.8% to $8.13. The market value of their outstanding shares is at $1.3 billion.
Losers
- Prime Medicine (NASDAQ:PRME) stock fell 19.2% to $1.28 during Monday's regular session. The company's market cap stands at $168.7 million.
- Plus Therapeutics (NASDAQ:PSTV) shares fell 16.67% to $0.35. The company's market cap stands at $2.0 million.
- Applied Therapeutics (NASDAQ:APLT) stock fell 15.4% to $0.51. The market value of their outstanding shares is at $72.2 million. The company's, Q1 earnings came out 4 days ago.
- Matinas BioPharma Hldgs (AMEX:MTNB) shares decreased by 13.53% to $0.75. The market value of their outstanding shares is at $3.8 million.
- Regencell Bioscience (NASDAQ:RGC) shares decreased by 12.81% to $342.68. The market value of their outstanding shares is at $4.4 billion.
- Liquidia (NASDAQ:LQDA) stock declined by 11.1% to $16.79. The market value of their outstanding shares is at $1.4 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.